RYSCX | VITAX | RYSCX / VITAX | |
Total Expense Ratio | 2.39 | 0.09 | 2,656% |
Annual Report Gross Expense Ratio | 2.44 | 0.09 | 2,711% |
Fund Existence | 24 years | 21 years | - |
Gain YTD | 16.932 | 12.436 | 136% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 91.2M | 117B | 0% |
Annual Yield % from dividends | 0.00 | 0.45 | - |
Returns for 1 year | 19.45 | 27.92 | 70% |
Returns for 3 years | 99.75 | 105.81 | 94% |
Returns for 5 years | 128.03 | 122.92 | 104% |
Returns for 10 years | 473.31 | 579.36 | 82% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTAX | 31.26 | 0.55 | +1.79% |
Fidelity Advisor Biotechnology A | |||
VDMAX | 10.53 | 0.10 | +0.96% |
Virtus KAR Developing Markets A | |||
COSYX | 14.14 | 0.06 | +0.43% |
Columbia Overseas Value Inst3 | |||
VGIRX | 15.69 | 0.03 | +0.19% |
Virtus Duff & Phelps Global Infras R6 | |||
PXWGX | 25.17 | -0.03 | -0.12% |
Impax US Sustainable Economy Investor |